Astera Labs, Inc. (ALAB) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Astera Labs: The Market's Overreaction Hands Long-Term Buyers A Gift
Astera Labs, Inc.'s revenue more than doubled year-over-year, while sequential growth slowed to mid-single digits, triggering valuation compression. ALAB's GAAP operating margin declined from mid-20% levels to below 20% as R&D rose to $93.8M, nearly 35% of revenue. Free cash flow margins remained strong above 30%, with $1.19B cash and zero debt reinforcing ALAB's financial flexibility.
Astera Labs bets on surging AI connectivity demand, expanding NVLink and Scorpio lines as its market opportunity eyes a 10x jump to $25B in five years.
Astera Labs (Nasdaq: ALAB) closed at $129.32 on February 13, 2026, down 23.86% over the past week.
Astera Labs is central to the AI infrastructure shift, enabling critical rack-level connectivity as hyperscaler capex accelerates. ALAB's multi-product ramp, including Scorpio and optical solutions, positions it as a strategic control point for rack-scale AI systems. Despite trading at a significant valuation premium, I reiterate a strong buy rating due to ALAB's expanding addressable market and unique platform role.
Astera Labs tumbles 31% after margin pressure hits Q4, despite AI demand, portfolio expansion, and strong Q1 guidance fueling growth hopes.
Astera Labs is rated 'hold' due to a rich valuation despite stellar Q4 results and a robust growth outlook. ALAB's diversified AI connectivity portfolio and software ecosystem drive 100%+ YoY revenue growth and expanding margins. Management guides for Q1 2026 revenue of $286-$297 million, citing strong hyperscaler demand and a $25B addressable market.
Revenue reached $270.6 million, up 17% sequentially and 92% year over year, with 75.7% gross margins and strong cash generation. First-quarter guidance implies 6%–10% sequential growth with gross margin stepping down to ~74% amid rising operating expenses. Scorpio X contributions are modest in early 2026, with meaningful volume ramps weighted toward the second half and into 2027.
ALAB tops Q4 earnings and revenue estimates on AI-driven growth, but shares tumble nearly 12% despite strong year-over-year gains.
Shares of Astera Labs tumbled on Wednesday despite a fourth-quarter earnings beat, as investors questioned the merits of the large deal with Amazon.
Astera Labs, Inc. (ALAB) Q4 2025 Earnings Call Transcript